Literature DB >> 17238819

Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement.

Philip W Smith1, Arthur O Anderson, George W Christopher, Theodore J Cieslak, G J Devreede, Glen A Fosdick, Carl B Greiner, John M Hauser, Steven H Hinrichs, Kermit D Huebner, Peter C Iwen, Dawn R Jourdan, Mark G Kortepeter, V Paul Landon, Patricia A Lenaghan, Robert E Leopold, Leroy A Marklund, James W Martin, Sharon J Medcalf, Robert J Mussack, Randall H Neal, Bruce S Ribner, Jonathan Y Richmond, Chuck Rogge, Leo A Daly, Gary A Roselle, Mark E Rupp, Anthony R Sambol, Joann E Schaefer, John Sibley, Andrew J Streifel, Susanna G Von Essen, Kelly L Warfield.   

Abstract

In spite of great advances in medicine, serious communicable diseases are a significant threat. Hospitals must be prepared to deal with patients who are infected with pathogens introduced by a bioterrorist act (e.g., smallpox), by a global emerging infectious disease (e.g., avian influenza, viral hemorrhagic fevers), or by a laboratory accident. One approach to hazardous infectious diseases in the hospital setting is a biocontainment patient care unit (BPCU). This article represents the consensus recommendations from a conference of civilian and military professionals involved in the various aspects of BPCUs. The role of these units in overall U.S. preparedness efforts is discussed. Technical issues, including medical care issues (e.g., diagnostic services, unit access); infection control issues (e.g., disinfection, personal protective equipment); facility design, structure, and construction features; and psychosocial and ethical issues, are summarized and addressed in detail in an appendix. The consensus recommendations are presented to standardize the planning, design, construction, and operation of BPCUs as one element of the U.S. preparedness effort.

Entities:  

Mesh:

Year:  2006        PMID: 17238819     DOI: 10.1089/bsp.2006.4.351

Source DB:  PubMed          Journal:  Biosecur Bioterror        ISSN: 1538-7135


  35 in total

1.  Biosecurity measures in 48 isolation facilities managing highly infectious diseases.

Authors:  Vincenzo Puro; Francesco M Fusco; Stefan Schilling; Gail Thomson; Giuseppina De Iaco; Philippe Brouqui; Helena C Maltezou; Barbara Bannister; René Gottschalk; Hans-Rheinhard Brodt; Giuseppe Ippolito
Journal:  Biosecur Bioterror       Date:  2012-05-09

2.  Considerations regarding safe transport and transfer for Ebola patients in western countries.

Authors:  Francesco Maria Fusco; Vincenzo Puro; Giuseppe Ippolito
Journal:  Intensive Care Med       Date:  2015-04-29       Impact factor: 17.440

3.  Successful delivery of RRT in Ebola virus disease.

Authors:  Michael J Connor; Colleen Kraft; Aneesh K Mehta; Jay B Varkey; G Marshall Lyon; Ian Crozier; Ute Ströher; Bruce S Ribner; Harold A Franch
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

4.  Critical care management of two patients with Ebola: a biocontainment unit demystified.

Authors:  Parizad Torabi-Parizi
Journal:  Crit Care Med       Date:  2015-06       Impact factor: 7.598

5.  Validation of Autoclave Protocols for Successful Decontamination of Category A Medical Waste Generated from Care of Patients with Serious Communicable Diseases.

Authors:  Brian T Garibaldi; Mallory Reimers; Neysa Ernst; Gregory Bova; Elaine Nowakowski; James Bukowski; Brandon C Ellis; Chris Smith; Lauren Sauer; Kim Dionne; Karen C Carroll; Lisa L Maragakis; Nicole M Parrish
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

Review 6.  Ebola haemorrhagic fever.

Authors:  Heinz Feldmann; Thomas W Geisbert
Journal:  Lancet       Date:  2011-03-05       Impact factor: 79.321

Review 7.  Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units.

Authors:  Angela L Hewlett; Jay B Varkey; Philip W Smith; Bruce S Ribner
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

8.  U.S. High-Level Isolation Unit Clinical Laboratory Capabilities Update.

Authors:  Jocelyn J Herstein; Peter C Iwen; Katelyn C Jelden; Paul D Biddinger; Shawn G Gibbs; Aurora B Le; Angela L Hewlett; John J Lowe
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

9.  Triage and management of accidental laboratory exposures to biosafety level-3 and -4 agents.

Authors:  Peter Jahrling; Colleen Rodak; Mike Bray; Richard T Davey
Journal:  Biosecur Bioterror       Date:  2009-06

10.  Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us.

Authors:  Jay B Varkey; Bruce S Ribner
Journal:  Microbiol Spectr       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.